The team behind the technology

Project Screen by Prenetics is an initiative developed by Prenetics, a healthcare company with headquarters in London and Hong Kong.

Our vision

We see a world where employers and employees can go back to pursuing the things they love in the way they love doing them. This will be enabled by frequent testing to offer peace of mind that those around you are healthy and virus free.

Project Screen by Prenetics and Prenetics

CircleDNA is a consumer-facing genetics product created by Prenetics, a healthcare company with headquarters in London and Hong Kong. The processes of DNA testing and COVID testing are similar in that they require a sample collection, lab processing and the secure delivery of results. With all these ingredients in place, Prenetics were able to launch Project Screen by Prenetics to meet the global demand for the COVID testing that would help support our economy to resume business as usual.


Avi Lasarow

Avi Lasarow, CEO EMEA Prenetics

Our partners

To deliver COVID testing at scale to the highest standards, Prenetics have created a consortium of cross functional experts including Anglia DNA, The Doctors Laboratory and University of Birmingham.

Our three guiding principles


Distributed testing for sports teams and employers

We're here to help Britain get back to work with a sense of normality. For now, that means making COVID-19 testing part of our routine so that employers and employees have the confidence to resume their services. Televised sport plays a big role in this, giving us something to rally behind as a nation.


Technology platform to manage population testing

Receiving a test is the beginning of the COVID-19 management. The next steps require the secure delivery of the results and the ability for employers to monitor the status of an individual. Project Screen by Prenetics has huge experience in this area from our DNA testing brands and has also created the innovative health passport system to ensure that a person’s COVID-19 status is current.


High capacity COVID-19 testing infrastructure

Project Screen by Prenetics supports both Antigen and Antibody testing, processing over 10,000 tests a week. We’re actively looking for ways to streamline our processes and scale up to meet the demand of the United Kingdom. We continue to work closely with The Doctors Laboratory, The University of Birmingham and Anglia DNA to ensure scale does not come at the cost of rigour.

Quality standards, rigour and accreditations

Quality standard

Our RT-PCR tests are quality standard, CE marked collection devices. Prenetics is regulated by the Care Quality Commission.

ISO-15189 & ISO-17025 accredited laboratories

Samples are processed in laboratories that are accredited by the United Kingdom Accreditation Service.

Reliable & convenient testing experience

We use well-established and effective collection methods that are simple to conduct at mobile testing locations across the country.

State-of-the-art security protocols

We are GDPR compliant and adhere to the leading international security standard, ISO 27001, with connections encrypted using SSL.

Prenetics leadership team

Danny Yeung

Group CEO (Co-founder) Prenetics/ CircleDNA

Avi Lasarow

CEO Prenetics EMEA & DNAfit, Hon. Consul South Africa to UK

Andrew Steele

Head of Product Prenetics EMEA & DNAfit

Rio Ferdinand

Subject Expert/ Player Engagement Prenetics EMEA & DNAfit

Brian Stephenson

Head of Operations, Prenetics EMEA & DNAfit

Jotika Behari

Data Information Security, Prenetics EMEA & DNAfit

Dereck Chisora

Subject Expert/ Player Engagement Prenetics EMEA & DNAfit

Prenetics’ expert scientific consortium

Dr. Rachel Liebmann

Group Medical Director, The Doctor’s Laboratory and Vice President of the Royal College of Pathologists

Dr. Mark Atkin

Consultant Virologist, The Doctor’s Laboratory

Dr. Senthil Sundaram, MD

Chief Clinical Officer at Prenetics; Leads clinical development of molecular genetic testing

Dr. Lawrence Tzang CH, BSc, PhD, Reg MLT

Chief Scientific Officer & Laboratory Director of Prenetics COVID-19 Screening Facility

Scientific working group

Prof. Alan McNally, BSC, PhD

Director of Institute of Microbiology and Infection, University of Birmingham

Prof. Willem Van Schaik, MSc, PhD

Institute of Microbiology and infection, University of Birmingham

Prof. Michael M Yang, PhD

Head and Chair Professor, Department of Biomedical Sciences at City University of Hong Kong

Dr. Richard H. Kaszynski, M.A, M.D,PhD

Co-Founder: Stanford Solutions, a healthcare innovation group founded out of Standard University School of Medicine. Executive Director, Shinwakai Medical Group, Tokyo, Japan

About CircleDNA

Circle is wholly owned by Prenetics Limited, a global market leader in digital health and genetic testing, dedicated to empowering individuals with valuable and actionable health information, who also owns DNAfit (a multiple Queen’s Award winning company). With over $50M in funding from 500 Startups, Beyond Ventures and more, Prenetics currently operates in 10 offices across the globe, including London, Singapore, Hong Kong, Kuala Lumpur, Johannesburg, and more. To-date, Prenetics has performed more than 300,000 DNA tests for customers worldwide.

About Project Screen by Prenetics

Project Screen is an initiative created by Prenetics, a genetics company with headquarters in London and Hong Kong. Together, we can get Britain back to work.

Social Media

© 2020 Project Screen | All rights reserved | Website by Hix